Last reviewed · How we verify
NCT06592716
Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?
trial testing Liquid biopsy in Oropharynx Cancer in 200 participants. Participants enrolled and being followed up; not accepting new ones.
31 December 2028
Quick facts
| Lead sponsor | Rigshospitalet, Denmark |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 2 April 2024 |
| Primary completion | 31 December 2028 |
| Estimated completion | 31 December 2028 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Liquid biopsy — full drug profile →
Conditions studied
- Oropharynx Cancer — all drugs for Oropharynx Cancer →
- Oropharynx Cancer, Metastatic — all drugs for Oropharynx Cancer, Metastatic →
- Oropharynx Cancer, Recurrent — all drugs for Oropharynx Cancer, Recurrent →
- Oropharyngeal Carcinoma — all drugs for Oropharyngeal Carcinoma →
Sponsor
Rigshospitalet, Denmark
Who can join
18 and older, any sex, with Oropharynx Cancer or Oropharynx Cancer, Metastatic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates if longitudinal analyses of cell-free HPV-DNA in blood samples can be utilized to detect recurrence in patients diagnosed and treated for HPV-positive oropharyngeal squamous cell carcinoma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06592716
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Liquid biopsy
Trials testing the same drug.
- NCT06605443 — Precision Medicine for L/GCMN and Melanoma 2 · recruiting
- NCT06283576 — Pancreatic Cancer Initial Detection Via Liquid Biopsy · enrolling by invitation
- NCT07418125 — Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA · NA · recruiting
- NCT06605417 — Understanding the Transition from Normal Melanocytes to Nevus to Melanoma · recruiting
- NCT06090214 — Liquid Biopsy for the Diagnosis of Intestinal-type Adenocarcinoma of the Ethmoid (BLADE) · NA · unknown
Other recruiting trials for Oropharynx Cancer
Currently open trials in the same condition.
- NCT05639972 — E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers · Phase 1, PHASE2 · recruiting
- NCT07063212 — A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) · Phase 2 · recruiting
- NCT07033091 — Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening · NA · recruiting
- NCT06309225 — Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly · NA · recruiting
- NCT06563362 — Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma · Phase 2 · recruiting
Other Rigshospitalet, Denmark trials
Trials by the same sponsor.
- NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
- NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
- NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
- NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
- NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06592716 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
- Last refreshed: 18 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06592716.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing